| Biological Sciences | Lifetime | 78 | US 46 | 99.99 |
| Molecular Biology | Lifetime | 19 | US 14 | 99.99 |
| Cancer Research | Lifetime | 70 | US 42 | 99.64 |
| Cell Biology | Lifetime | 118 | US 74 | 99.41 |
| Oncology | Lifetime | 680 | US 375 | 98.65 |
| Medical Physiology | Lifetime | 828 | US 424 | 98.46 |
| Hepatology | Lifetime | 615 | US 218 | 91.27 |
| Medical Genetics | Lifetime | 889 | US 444 | 88.63 |
| Molecular Biology | 2021-2025 | 623 | US 179 | 96.62 |
| Cancer Research | 2021-2025 | 270 | US 100 | 84.91 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 1 | US 1 | 99.99 |
| Protein Kinase Regulation and GTPase Signaling | Lifetime | 1 | US 1 | 99.97 |
| Cancer, Hypoxia, and Metabolism | Lifetime | 9 | US 7 | 99.95 |
| Metabolism, Diabetes, and Cancer | Lifetime | 10 | US 7 | 99.89 |
| Cellular transport and secretion | Lifetime | 23 | US 14 | 99.75 |
| Ubiquitin and proteasome pathways | Lifetime | 59 | US 33 | 99.59 |
| Pancreatic function and diabetes | Lifetime | 113 | US 57 | 99.52 |
| Protein Tyrosine Phosphatases | Lifetime | 25 | US 15 | 98.50 |
| Liver physiology and pathology | Lifetime | 70 | US 30 | 99.17 |
| FOXO transcription factor regulation | Lifetime | 14 | US 10 | 98.36 |
| Renal and related cancers | Lifetime | 166 | US 103 | 99.02 |
| Erythrocyte Function and Pathophysiology | Lifetime | 174 | US 107 | 98.49 |
| Ion Transport and Channel Regulation | Lifetime | 113 | US 56 | 98.38 |
| Monoclonal and Polyclonal Antibodies Research | Lifetime | 816 | US 423 | 98.70 |
| 14-3-3 protein interactions | Lifetime | 34 | US 21 | 97.12 |
| ATP Synthase and ATPases Research | Lifetime | 130 | US 47 | 98.26 |
| Peptidase Inhibition and Analysis | Lifetime | 488 | US 224 | 98.25 |
| RNA modifications and cancer | Lifetime | 916 | US 440 | 98.32 |
| Biochemical and Molecular Research | Lifetime | 297 | US 189 | 97.76 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 583 | US 271 | 98.50 |
| Epigenetics and DNA Methylation | Lifetime | 897 | US 458 | 98.03 |
| Mitochondrial Function and Pathology | Lifetime | 773 | US 312 | 97.86 |
| Cancer-related Molecular Pathways | Lifetime | 712 | US 378 | 97.65 |
| HER2/EGFR in Cancer Research | Lifetime | 512 | US 236 | 97.91 |
| Endoplasmic Reticulum Stress and Disease | Lifetime | 456 | US 217 | 97.04 |
| Cell Adhesion Molecules Research | Lifetime | 1,000 | US 489 | 97.29 |
| Melanoma and MAPK Pathways | Lifetime | 317 | US 171 | 96.69 |
| Tuberous Sclerosis Complex Research | Lifetime | 101 | US 60 | 95.28 |
| Neonatal Health and Biochemistry | Lifetime | 708 | US 352 | 95.65 |
| interferon and immune responses | Lifetime | 865 | US 355 | 95.40 |
| Cancer Mechanisms and Therapy | Lifetime | 562 | US 233 | 94.71 |
| Protein Degradation and Inhibitors | Lifetime | 699 | US 343 | 95.41 |
| Mast cells and histamine | Lifetime | 601 | US 204 | 94.84 |
| Vanadium and Halogenation Chemistry | Lifetime | 248 | US 51 | 94.92 |
| Toxin Mechanisms and Immunotoxins | Lifetime | 922 | US 436 | 93.71 |
| Calcium signaling and nucleotide metabolism | Lifetime | 330 | US 113 | 93.45 |
| Hippo pathway signaling and YAP/TAZ | Lifetime | 463 | US 201 | 92.21 |
| Biomedical Research and Pathophysiology | Lifetime | 705 | US 287 | 87.47 |
| Cancer, Hypoxia, and Metabolism | 2021-2025 | 134 | US 33 | 96.07 |
| PI3K/AKT/mTOR signaling in cancer | 2021-2025 | 33 | US 21 | 93.88 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 172 | US 51 | 94.36 |
| Advanced Proteomics Techniques and Applications | 2021-2025 | 939 | US 335 | 68.79 |
| Protein Kinase Regulation and GTPase Signaling | 2021-2025 | 409 | US 183 | 60.36 |
